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Abstract: 
Purpose: Many retinal diseases lead to the loss of retinal neurons, resulting in significant visual 
impairment and blindness. In mammals, there is no regenerative response to replenish lost neurons 
and restore vision. However, retinal regeneration occurs in chick and zebrafish where lost neurons 
are regenerated. Müller glia, the primary glial cell of the retina, are the source of these regenerated 
neurons. Müller glia detect retinal damage, de-differentiate into progenitor cells, and progeny 
differentiate to become neurons. The transition from glia to neuron requires reorganization of 
chromatin architecture, which is accomplished through epigenetic regulation and histone 
modifications. The polycomb repressor complex 2 (PRC2) is a histone methylase that regulates 
retinal development, and knockout of the catalytic subunit EZH2 results in microphthalmia. Thus, 
we hypothesize that the PRC2 complex is necessary for the repression of glial fate genes, 
permitting Müller glia to de-differentiation and become progenitor-like cells. Therefore, we 
investigated the epigenetic regulation of Müller glia reprogramming. 
Research Methods: Postnatal White Leghorn chicks (P7-14) were intravitreally injected with 
excitotoxin N-methyl-D-aspartate (NMDA) to induce retinal damage and initiate Müller glia 
reprogramming. We administered EZH2 inhibitor 3-Deazaneplanocin A (DZN) to determine the 
impact on the formation of proliferating Müller glia derived progenitor cells. We enucleated, fixed, 
and sectioned the tissue for fluorescence immunohistochemistry (IHC). We quantified the number 
of progenitors that entered the cell cycle by staining for the incorporation of nuclear 5-Ethynyl-2'-
deoxyuridine (EdU) to colocalize with Müller glia/progenitor markers Sox2/Sox9. Retinal 
preparations were dissociated for single cell analysis. We performed single cell RNA sequencing 
(scRNA-seq) and a single cell Assay for Transposase-Accessible Chromatin sequencing 
(scATAC-seq) on damaged, undamaged, and DZN treated retinas to determine how changes in 
chromatin remodeling and gene expression occurred during reprogramming and were influenced 
by inhibition of EZH2. 
Results: We found that EZH2 and other components of the PRC2 complex are specifically 
upregulated in Müller glia during the de-differentiation process to form Müller glia derived 
progenitor cells. Single cell sequencing indicates an upregulation of EZH2, EED, SET and RBBP4. 
IHC of EZH2 protein also colocalized with Müller glia nuclei after damage. The inhibition of 
EZH2 with DZN blocked the formation of progenitor cells after damage. scRNA-seq analysis 
demonstrated that EZH2-inhibition significantly influenced gene expression and chromatin access. 
This led to increased expression in glial transcription factors (ID4, NFIA, SOX8) in damaged 
retinas, while also increasing reactive glial genes (ATF4, NFIX, NEFM, DCX, HES1). When 
observing chromatin accessibility in scATAC-seq data, DZN treatment increased access to many 
important genes, including pro-glial factors such as ID4 and NFIX. Genomic regions surrounding 
both glial (NOTCH1, GLI2) and neuronal (HEYL1, LHX9) transcription factors were also more 
accessible as a result of inhibiting the PRC2 complex. 
Implications: We find that PRC2 complex genes are upregulated in Müller glia-derived 
progenitors during reprogramming. We demonstrate the pharmacological inhibition of EZH2 
robustly negates the transition from glia to progenitor cell after damage. Single cell analyses of 
chromatin accessibility indicate that this repressive histone methylase condenses chromatin around 
transcription factors that promote mature glial or neuronal phenotype. These epigenetic 
modifications correlate to the increased expression glial genes the repress a progenitor cell 
phenotype. We identify genes that may be key regulators of Müller glia’s response to damage and 
are required for the transition into progenitor cells. These findings provide new insight into how 
epigenetic factors impact regeneration in the retina and central nervous system. Future 
experimentation is required to study how histone modifications influence the poor regenerative 
response in the retinas of mammals.  
  
Introduction: 
Müller glia (MG) are the predominant type of support cell in the retina. These glia are 
common to all vertebrate classes. MG perform many important glial functions including 
structural support, synaptic support, osmotic homeostasis, and nutritive/metabolic support to 
retinal neurons. However, MG also have the extraordinary capability to de-differentiate, 
proliferate, acquire progenitor phenotype, and generate new neurons (1–5). It must be noted that 
in normal, healthy retinas MG are distinctly different from retinal progenitor cells based on 
cellular functions and transcriptional profile. It is believed that cellular reprogramming underlies 
that the transition of MG into progenitor cells. Reprogramming of MG involves down-regulation 
of glial genes, up-regulation of progenitor-associated factors, proliferation, followed by neuronal 
differentiation. Cellular proliferation is thought to be an integral step of MG becoming 
progenitor-like cells (6,7). In the chick model system, we were the first to demonstrate that MG 
can become progenitor cells that regenerate neurons (8). In response to N-methyl-D-aspartate 
(NMDA) -induced damage, numerous MG de-differentiate, re-enter the cell-cycle, and express 
transcription factors which are found in embryonic retinal progenitors (8–11). In response to 
sufficient levels of neuronal damage, numerous MG undergo a single round of division in vivo; 
these cells continue to proliferate when they are dissociated and grown in culture (8), suggesting 
that the intact retina provides cues to suppress the formation of Müller glia-derived progenitor 
cells (MGPCs). In vivo, the majority (about 80%) of cells that are generated by proliferating 
MGPCs remain as un-differentiated progenitor cells, some differentiate into MG and a few 
differentiate into neurons. Although few neurons are regenerated, MGPCs produce thousands of 
undifferentiated cells that could be stimulated to differentiate as neurons to restore vision. 
With a few exceptions, the formation of MGPCs is stimulated by severe acute retinal 
damage. One exception is consecutive daily injections of Fibroblast Growth Factor 2 (FGF2) 
and/or insulin/IGF1 which activates a network of cell-signaling pathways to stimulate the 
formation of neurogenic MGPCs in the chick retina, in the absence of damage (12,13), but this 
requires the presence of reactive microglia (13). In the zebrafish retina, activation of Wnt-
signaling or MAPK-signaling via HB-EGF or FGF+insulin can stimulate the formation of 
MGPCs and de novo neurogenesis (14–16). Further, TNFα combined with Notch-inhibitor is 
sufficient to stimulate the formation of MGPCs and de novo neurogenesis in zebrafish retina 
(17,18). In the mouse model, recent studies indicated that forced-expression of the transcription 
factor Ascl1a, in combination with NMDA-induced damage and HDAC-inhibitor, stimulates 
reprogramming of MG into functional, light-responsive neurons (19–21). Further evidence in the 
mouse suggests that activation of Wnt/β-catenin and forced expression of photoreceptor 
transcription factors (Otx2, Crx, Nrl) stimulates proliferation and reprograming of MG into rod 
photoreceptors (22). It makes no sense to stimulate neural regeneration from MG in slowly 
degenerating retinas by inducing severe, acute damage. Thus, identification of the secreted 
factors, transcription factors and signaling pathways that stimulate MG without further damaging 
retinal neurons is crucial to harnessing the neurogenic potential of these glia.  
Our findings in the chick retina have guided studies involving MG as a cellular source of 
neural regeneration in mammals (4,5) and zebrafish (3,23). By comparison, MG in the fish retina 
have an extraordinary capacity to regenerate retinal neurons whereas MG in the mammalian 
retina have very restricted capacity.  Interestingly, MG in the chick retina have a neurogenic 
potential that lies between than of fish and mammals.  Collectively, these observations raise 
important questions as to why MG in fish regenerate numerous functional neurons, whereas this 
potential is restricted in birds and blocked in mammals?  
The purpose of the studies proposed herein is to understand how the activity of EZH2 
regulates the dedifferentiation of MG, reprogramming into proliferating MGPCs, and the 
neuronal differentiation of the progeny of MGPCs. There is nothing known regarding the roles of 
EZH2 (enhancer of zeste 2) and polycomb repressor complex (PRC2) in mature MG and the 
formation of MGPCs in the retina. EZH2 is histone-lysine N-methyltransferase that can 
influence many cellular processes including proliferation and differentiation. The canonical 
functions of EZH2 involve participation in the polycomb repressive complex 2 (PRC2) which 
suppresses transcription via tri-methylation of H3K27.  PRC2 is comprised not only EZH2, but 
also regulatory/catalytic subunits EED, SUZ12, RBP48 and SET. EZH2 is also known to have 
non-canonical functions which can include methylation of Stat3 and RORα, transcriptional 
activation following phosphorylation by JAK3, and methylation-independent promotion of 
cyclin D, Notch1 and Wnt-related genes   (24,25). EZH2 is known to promote the proliferation 
of early stage retinal progenitors and differentiation of late-born neurons and glia (26–28).  
Further, embryonic deletion of Ezh2 from the retina results in postnatal degeneration of 
photoreceptors, likely because of failure to suppress embryonic transcription factors (29). Some 
of the gene-repressing actions of EZH2 may be guided by interactions Six3 and Six6, as well as 
the lcRNA Six3OS (29,30), and these genes are prominently expressed by MG and MGPCs in 
normal and damaged retinas according to preliminary data from scRNA-seq on cells from mouse 
and chick retinas (not shown). Currently, there is nothing known about the functions of EZH2 in 
mature MG and during the formation of MGPCs. Accordingly, we propose to investigate how 
EZH2 influences glial phenotype, de-differentiation MG, proliferation of MGPCs and neuronal 
differentiation in vivo.  My laboratory will investigate how EZH2-activity impacts MG and 
MGPCs using the chick and mouse model systems. The chick model provides an efficient and 
cost-effective means to investigate the efficacy and specificity of pharmacological agents upon 
MG and MGPCs. The eyes of chicks are large and readily tolerate repeated intraocular 
injections. In future studies, we will compare data from zebrafish, chick and rodent model 
systems, which is expected to provide important, novel insights into the differences in MG 
plasticity and regenerative capacity of MGPCs. For example, a comparative cross-species 
approach has been applied to generate significant volumes of data using RNA-seq, scRNA-seq 
and ATAC-seq of MG and MGPCs from zebrafish, chick and mouse retinas (31). There already 
exists significant volumes of data regarding the networks of cell-signaling pathways and 
transcription factors that are involved in the formation of MGPCs in different the different model 
systems (Reviewed by (32,33)).   
  
Methods and Materials:  
Animals:  
The animals approved for use in these experiments was in accordance with the guidelines 
established by the National Institutes of Health and IACUC at The Ohio State University. Newly 
hatched P0 wildtype leghorn chicks (Gallus gallus domesticus) were obtained from Meyer 
Hatchery (Polk, Ohio). Post-hatch chicks were maintained in a regular diurnal cycle of 12 hours 
light, 12 hours dark (8:00 AM-8:00 PM). Chicks were housed in stainless-steel brooders at 25oC 
and received water and Purinatm chick starter ad libitum.   
Fertilized eggs were obtained from the Michigan State University, Department of Animal 
Science. Eggs were incubated at a constant 37.5°C, with a 1hr period room temperature cool 
down every 24hrs. Additionally, the eggs were rocked every 45 minutes, and held at a constant 
relative humidity of 45%. Embryos were harvested at various time points after incubation and 
staged according to guidelines established by Hamburger and Hamilton (1951).   
  
Intraocular injections:  
Chicks were anesthetized with 2.5% isoflurane mixed with oxygen from a non-
rebreathing vaporizer. The technical procedures for intraocular injections were performed as 
previously described (Fischer et al., 1998). With all injection paradigms, both pharmacological 
and vehicle treatments were administered to the right and left eye respectively. Compounds were 
injected in 20 ml sterile saline with 0.05 mg/ml bovine serum albumin added as a carrier. 
Compounds included: NMDA (38.5nmol or 154 µg/dose; Sigma-Aldrich), FGF2 (250 ng/dose; 
R&D systems), DZNexp4 (200 ng/dose; Tocris), EEDi (200 ng/dose; Tocris), UNC1999 (200 
ng/dose; Tocris), GSK126 (200 ng/dose; Tocris), GSK343 (200 ng/dose; Tocris), JIB 04 (200 
ng/dose; Tocris).  5-Ethynyl-2´-deoxyuridine (EdU) was intravitreally injected to label the nuclei 
of proliferating cells. Injection paradigms are included in each figure.   
  
Preparation of clodronate liposomes:  
Clodronate liposomes were synthesized utilizing a modified protocol from previous 
descriptions (Van Rooijen, 1989; van Rooijen, 1992; Zelinka et al., 2012).  In short, 
approximately 8 mg of L-α-Phosphatidyl-DL-glycerol sodium salt (Sigma P8318) was dissolved 
in chloroform. 50 mg of cholesterol was dissolved in chloroform with the lipids in a 
sterile microcentrifuge tube. This tube was rotated under nitrogen gas to evaporate the 
chloroform and leave a thin lipid-film on the walls of the tube. 158 mg dichloro-methylene 
diphosphonate (clodronate; Sigma-Aldrich) dissolved sterile PBS (pH 7.4) was added to the 
lipid/cholesterol film and vortexed for 5 minutes. To reduce size variability of lipid vesicles, the 
mixture was sonicated at 42 kHz for 6 minutes. Purification of liposomes was accomplished via 
centrifugation at 10,000 x G for 15 minutes, aspirated, and resuspended in 150 µl PBS. Each 
retinal injection used between 5 and 20 ul of clodronate-liposome solution. There was a variable 
yield of clodronate-liposomes during the purification resulting in some variability per dose. The 
dosage was adjusted such that >98% of the microglia are ablated by 2 days after administration 
with no off-target cell death or pigmented epithelial cells.  
  
Single Cell RNA and ATAC sequencing of retinas     
Retinas were obtained from embryonic and postnatal chicks. Isolated retinas were 
dissociated in a 0.25% papain solution in Hank’s balanced salt solution (HBSS), pH = 7.4, for 30 
minutes, and suspensions were frequently triturated. The dissociated cells were passed through a 
sterile 70µm filter to remove large particulate debris. Dissociated cells were assessed for 
viability (Countess II; Invitrogen) and cell-density diluted to 700 cell/µl. Each single cell cDNA 
library was prepared for a target of 10,000 cells per sample. The cell suspension and Chromium 
Single Cell 3’ V2 reagents (10X Genomics) were loaded onto chips to capture individual cells 
with individual gel beads in emulsion (GEMs) using 10X Chromium Controller. cDNA and 
library amplification for an optimal signal was 12 and 10 cycles respectively. Sequencing was 
conducted on Illumina HiSeq2500 (Genomics Resource Core Facility, John’s Hopkins 
University) or HiSeq4000 (Novogene) with 26 bp for Read 1 and 98 bp for Read 
2. Fasta sequence files were de-multiplexed, aligned, and annotated using the chick ENSMBL 
database (Chick-5.0, Ensembl release 94) and Cell Ranger software. Gene expression 
was counted using unique molecular identifier bar codes, and gene-cell matrices were 
constructed. Using Seurat toolkits, t-distributed stochastic neighbor embedding (tSNE) plots or 
Uniform Manifold Approximation and Projection for Dimension Reduction (UMAP) plots were 
generated from aggregates of multiple scRNA-seq libraries (Butler et al., 2018; Satija et al., 
2015). Compiled in each tSNE/UMAP plot are two biological library replicates for each 
experimental condition. Seurat was used to construct violin/scatter plots. Significance of 
difference in violin/scatter plots was determined using a Wilcoxon Rank Sum test 
with Bonferroni correction. Monocle was used to construct unbiased pseudo-time trajectories and 
scatter plotters for MG and MGPCs across pseudotime (Qiu et al., 2017a; Qiu et al., 
2017b; Trapnell et al., 2012). Genes that were used to identify different types of retinal cells 
included the following: (1) Müller glia: GLUL, VIM, SCL1A3, RLBP1, (2) MGPCs: PCNA, 
CDK1, TOP2A, ASCL1, (3) microglia: C1QA, C1QB, CCL4, CSF1R, TMEM22, (4) ganglion 
cells: THY1, POU4F2, RBPMS2, NEFL, NEFM, (5) amacrine cells: GAD67, CALB2, TFAP2A, 
(6) horizontal cells: PROX1, CALB2, NTRK1, (7) bipolar cells: VSX1, OTX2, GRIK1, GABRA1, 
and (7) cone photoreceptors: CALB1, GNAT2, OPN1LW, and (8) rod photoreceptors: RHO, 
NR2E3, ARR3. The MG have an over-abundant representation in the scRNA-seq databases. This 
likely resulted from fortuitous capture-bias and/or tolerance of the MG to the dissociation 
process. scRNA-seq libraries for retinas treated with NMDA and/or insulin and FGF2 can be 
queried at: https://proteinpaint.stjude.org/F/2019.retina.scRNA.html  
  
Fixation, sectioning and immunocytochemistry:  
Retinal tissue samples were formaldehyde fixed, sectioned, and labeled via 
immunohistochemistry as described previously (Fischer et al., 2008; Fischer et al., 2009c). 
Antibody dilutions and commercial sources for images used in this study are described in table 2. 
Observed labeling was not due to off-target labeling of secondary antibodies or 
tissue autofluorescence because sections incubated exclusively with secondary antibodies were 
devoid of fluorescence. Secondary antibodies utilized include donkey-anti-goat-Alexa488/568, 
goat-anti-rabbit-Alexa488/568/647, goat-anti-mouse-Alexa488/568/647, goat-anti-rat-Alexa488 
(Life Technologies) diluted to 1:1000 in PBS and 0.2% Triton X-100.  
  
Labeling for EdU:  
For the detection of nuclei that incorporated EdU, immunolabeled sections were fixed in 
4% formaldehyde in 0.1M PBS pH 7.4 for 5 minutes at room temperature. Samples were washed 
for 5 minutes with PBS, permeabilized with 0.5% Triton X-100 in PBS for 1 minute at room 
temperature and washed twice for 5 minutes in PBS. Sections were incubated for 30 minutes at 
room temperature in a buffer consisting of 100 mM Tris, 8 mM CuSO4, and 100 mM ascorbic 
acid in dH2O. The Alexa Fluor 568 Azide (Thermo Fisher Scientific) was added to the buffer at a 
1:100 dilution.  
  
Terminal deoxynucleotidyl transferase dUTP nick end labeling (TUNEL):  
The TUNEL assay was implemented to identify dying cells by imaging fluorescent 
labeling of double stranded DNA breaks in nuclei. The In Situ Cell Death Kit (TMR red; Roche 
Applied Science) was applied to fixed retinal sections as per the manufacturer’s instructions.  
  
Photography, measurements, cell counts and statistics:  
Microscopy images of retinal sections were captured with the Leica DM5000B 
microscope with epifluorescence and the Leica DC500 digital camera. High resolution confocal 
images were obtained with a Leica SP8 available in The Department of Neuroscience Imaging 
Facility at The Ohio State University. Representative images are modified to have enhanced 
color, brightness, and contrast for improved clarity using Adobe Photoshop. For quantification of 
numbers of EdU+ cells, a fixed region of retina was counted and average numbers of 
Sox2+/CD45+ and EdU co-labeled cells. The retinal region selected cell counts was standardized 
between treatment and control groups to reduce variability and improve reproducibility.   
Similar to previous reports (Fischer et al., 2009a; Fischer et al., 2009b; Ghai et al., 2009), 
immunofluorescence was quantified by using ImagePro6.2 (Media Cybernetics, Bethesda, MD, 
USA) or Image J (NIH). Identical illumination, microscope, and camera settings were used to 
obtain images for quantification. Retinal areas were sampled from 5.4 MP digital images. These 
areas were randomly sampled over the inner nuclear layer (INL) where the nuclei of the bipolar 
and amacrine neurons were observed. The density sum was calculated as the total of pixel values 
for all pixels within thresholded regions. The mean density sum was calculated for the pixels 
within threshold regions from ≥5 retinas for each experimental condition. GraphPad Prism 6 was 
used for statistical analyses.  
For statistical evaluation of differences in treatments, a two-tailed paired t-test was 
applied for intra-individual variability where each biological sample also served as its own 
control. For two treatment groups comparing inter-individual variability, a two-tailed unpaired t-
test was applied. For multivariate analysis, an ANOVA with the associated Tukey Test was used 
to evaluate any significant differences between multiple groups.  
Results & Conclusions 
 The role of EZH2 was investigated in the formation of Müller glia progenitor cells after 
NMDA damage. First, using single cell RNA sequencing, we were able to probe the different 
cell types of the chick retina to detect the various different components of the PRC2 complex, 
such as the catalytic unit EZH2. After damage, the forming progenitor cells upregulate EZH2, 
along with other cell cycle markers (Fig1a-e). This upregulation can also be visualized through 
the violin plot and pseudotime which models the transition from glial cell to progenitor cell 
Fig(1e-g). 
 The upregulation of the transcripts of EZH2 was also matched with a increase in the 
protein expression of EZH2 (Fig.2). EZH2 is not detected in Müller glia in undamaged retina, 
but after 48hrs, the nuclei of Sox9 positive Müller glia were positive for EZH2 immunolabelling 
(Fig2a-c). Other cells were positive for EZH2 as well, including microglia as evidenced by the 
CD45 EZH2 colocalization (Fig2c). This suggests that EZH2 has functional roles in cellular 
proliferation in addition to potential roles facilitating the reprogramming of Müller glia. 
 To establish a functional dependence on EZH2 function for reprogramming, we used 
DZN as a target specific small molecule inhibitor after damage and measure the number of 
proliferating progenitor cells. We observed that with the administration of DZN, there was a 
significant decrease in the number EdU+ Sox2+ progenitor cells in the chick retina (Fig 3). This 
shows that there is a functional dependence on the function of EZH2 to enable the process of de-
differentiation and proliferation of Müller glia into progenitor like cells.  
 We took the DZN inhibited retinas, and created scRNA-seq libraries of the retinas with 
and without NMDA excitotoxic damaged retinas. The results showed that the DZN treated 
retinas without damage were significantly different than the DZN untreated retinas, as they 
expressed several more glia markers and transcription factors while also downregulating the 
amount of proliferation factors (Fig 4). Similarly, this was also true of the NMDA plus DZN 
treated retinas, but to a lesser degree. We are still investigating why there was such a larger 
significant difference in the undamaged condition. Part of the limitation of the NMDA DZN 
treated retinas is that there was a very limited sample size of MG that passed our quality control 
metrics, thus limited the amount of analysis that could be done. 
 In conclusion, this data provides novel evidence that the PRC2 complex, specifically the 
catalytic unit EZH2 serves a necessary role in transitioning mature Müller glia into proliferating 
progenitor cells. The large data collected from the single cell RNA sequencing suggests that 
EZH2 may normally be repressing pro-glial genes that repress the de-differentiation process and 
that without this epigenetic repression, the regenerative capacity of these cells between species 
may be limited. Future work will be validating the regions of epigenetic modulation to improve 
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Figure 1. Expression of PRC2-related(Ghai et al., 2010; Palazzo et al., 2019; Todd and Fischer, 
2015; Todd et al., 2016; Zelinka et al., 2016) genes in retinal cells following NMDA-treatment 
of the chick retina. scRNA-seq was used to identify patterns of expression of EZH2-related 
genes among acutely dissociated retinal cells. In tSNE (a-c), violin (d,g,j), pseudotime (e,f) and 
UMAP plots (h,i), each dot represents one cell. In tSNE and UMAP plots black dots demonstrate 
individual cells that express 2 or more markers.  Cells were obtained from control retinas (16,595 
cells), and from retinas at 24hrs (14,918 cells), 48hrs (8483 cells) and 72 hrs (18,338 cells) after 
NMDA-treatment (a).  tSNE plots revealed distinct clustering of different types of retinal cells; 
control MG (5468 cells), 24 hr NMDA-treated MG (12,576 cells), 48+72 hrs NMDA-treated 
MG (18,848 cells), MGPCs (5336 cells), microglia (66 cells), oligodendrocytes (1494 cells), 
NIRG cells (1224 cells), retinal ganglion cells (RGCs; 2049 cells), amacrine cells (2635 cells), 
bipolar cells (5169 cells), rod photoreceptors (974 cells), and cone photoreceptors (2495 cells) 
Pseudotime trajectories for MG and MGPCs revealed a branched trajectory with resting MG, 
proliferating MGPCs, and activated MG from 72hr after NMDA treatment largely confined to 
different branches (e). UMAP plots illustrate distinct clustering of MG from 48hrs after NMDA 
treated plus/minus insulin+FGF2 treatment (h).  UMAP plots demonstrate patterns of expression 
for GLUL, RLBP1 and VIM (Muller glia), TOP2A, PCNA and CDK1 (MGPCs), (h, i). 
Violin/scatter plots indicate significant differences (**p<0.001, ***p<<0.0001; Wilcox rank sum 
with Bonferroni correction) in expression of GLUL, CDK1, TOP2A among MG and MGPCs (j). 
    
Figure 3. EZH2 immunolabelling increased in proliferating MGPCs in damaged retinas.  
Chick eyes were injected with NMDA. Eyes were harvested at 24 hrs after the last injection and 
retinas processed for immunolabeling. Retinas were labeled for Sox2 (red) and EZH2+ (green) 
cells (a,b), or CD45 (c). Arrows indicate the nuclei of MG. The calibration bar panels a, b and c 
represent 50 µm. Abbreviations: ONL – outer nuclear layer, INL – inner nuclear layer, IPL – 
inner plexiform layer, GCL – ganglion cell layer, NF – neurofilament 
 
Figure 3. DZN decreases numbers of proliferating MGPCs in damaged retinas.  
Chick eyes were injected with NMDA, DZN, and EdU according to the  paradigm at the top 
figure. Eyes were harvested at 24 hrs after the last injection and retinas processed for 
immunolabeling. Retinas were labeled for Sox9 (green) and EdU+ (red) cells (a), and PCNA 
(blue).  Histograms illustrate the mean (± SD) and each dot represents one biological replicate. 
Significance of difference ( **p<0.01, ***p<0.001) was determined by using a paired t-test. 
Arrows indicate the nuclei of MG. The calibration bar panel a represent 50 µm. Abbreviations: 
ONL – outer nuclear layer, INL – inner nuclear layer, IPL – inner plexiform layer, GCL – 
ganglion cell layer, NF – neurofilament, 
 
Figure 4. Inhibition of EZH2 with DZN results in a significant downregulation of proliferation 
genes and genes for neuronal differentiation. genes in retinal cells following NMDA-treatment of 
the chick retina. scRNA-seq was used to identify patterns of expression of proliferation and 
neurodifferentiation-related genes among acutely dissociated retinal cells. In UMAP (a-c), violin 
each dot represents one cell.  UMAP plots demonstrate patterns of clustering for differently 
treated retina for Müller glia. The dot plot is organized by proliferation, transcription factor, 
HMG, secreted factor, chromatin access, and neuronal differentiation among the different 
treatments. They are colorized by feature changes to highlight the changes between the different 
features listed in the plot. 
 
